The #1 prescribed biologic for Crohn's & UC. *For UC and Crohn's patients combined. Quarterly analysis of claims data from June 2022 to September 2023.

*For UC and Crohn's patients combined. Quarterly analysis of claims data from June 2022 – September 2023.

Patient Portrayal

For adults with moderate to severe ulcerative colitis (UC) or Crohn's disease

The ENTYVIO Pen:
MAINTENANCE THERAPY OPTION* AT HOME OR ON THE GO

ENTYVIO Pen (vedolizumab) 108 mg.

*After at least 2 intravenous (IV) starter doses

Please select your condition

Moderate to Severe Ulcerative Colitis Moderate to Severe Crohn's Disease

What is ENTYVIO?

ENTYVIO is a prescription medicine used in adults for the treatment of:

  • moderately to severely active ulcerative colitis
  • moderately to severely active Crohn's disease

You weren’t made for moderate to severe
UC or Crohn’s. But ENTYVIO is.

ENTYVIO is a biologic treatment for people with ulcerative colitis (UC) or Crohn’s disease. In clinical trials, ENTYVIO helped many people achieve long-term relief and remission.

Whether you are just starting to learn about biologics or looking to try a new treatment, you’re in the right place. Here, you’ll find information about what causes UC and Crohn’s disease, how ENTYVIO works, cost and financial information, and more. And if you’re a current ENTYVIO patient, we have the support you’re looking for with our EntyvioConnect program.

ENTYVIO is the #1 prescribed biologic for UC and Crohn's.* To learn more, choose a disease above or see the study results below.

*For Crohn’s and UC patients combined. Quarterly analysis of claims data from June 2022 – September 2023.

Click Here for Information on CORONAVIRUS (COVID-19)